Trials / Conditions / Urinary Bladder Neoplasm

Urinary Bladder Neoplasm

21 registered clinical trials studyying Urinary Bladder Neoplasm — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069	Eli Lilly and Company	Phase 1
Active Not Recruiting	A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors NCT06238479	Eli Lilly and Company	Phase 1
Recruiting	Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab NCT06237920	The Netherlands Cancer Institute	Phase 2
Recruiting	DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/ NCT05786716	Cancer Research UK	Phase 2 / Phase 3
Unknown	SOX2 & PDL1 Expression on Urinary Bladder Carcinoma NCT05429710	Sohag University	—
Unknown	Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses NCT05097105	Sohag University	—
Active Not Recruiting	CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood NCT04811846	University Teaching Hospital Hall in Tirol	N/A
Completed	Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder NCT04576286	Ain Shams University	Phase 2
Active Not Recruiting	Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies NCT04561362	BicycleTx Limited	Phase 1 / Phase 2
Recruiting	Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy NCT04442724	Cedars-Sinai Medical Center	N/A
Completed	Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer NCT05946369	Ain Shams University	—
Unknown	The Importance of Muscle Function in Patients With Disseminated Bladder Cancer NCT04144270	Rigshospitalet, Denmark	—
Unknown	Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours NCT04029948	Mansoura University	N/A
Completed	A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Lo NCT03785925	Nektar Therapeutics	Phase 2
Completed	Evaluation of NanoDoce® in Participants With Urothelial Carcinoma NCT03636256	NanOlogy, LLC	Phase 1 / Phase 2
Terminated	Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma NCT03389438	Beijing Huanxing Cancer Hospital	Phase 2
Terminated	A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors NCT02952989	Seagen Inc.	Phase 1
Completed	Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiv NCT02977143	Seoul National University Hospital	N/A
Completed	The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep NCT02966535	Seoul National University Hospital	N/A
Completed	Confocal Microscopy Dual Band in the Management of Bladder Cancer NCT02857634	Lille Catholic University	—
Completed	Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer NCT02311101	The University of Texas Health Science Center at San Antonio	Phase 1